Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A

Adeno-associated virus (AAV)-mediated gene therapy may provide durable protection from bleeding events and reduce treatment burden for people with hemophilia A (HA). However, pre-existing immunity against AAV may limit transduction efficiency and hence treatment success. Global data on the prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Klamroth, Robert, Hayes, Gregory, Andreeva, Tatiana, Gregg, Keith, Suzuki, Takashi, Mitha, Ismail Haroon, Hardesty, Brandon, Shima, Midori, Pollock, Toni, Slev, Patricia, Oldenburg, Johannes, Ozelo, Margareth C., Stieltjes, Natalie, Castet, Sabine-Marie, Mahlangu, Johnny, Peyvandi, Flora, Kazmi, Rashid, Schved, Jean-François, Leavitt, Andrew D., Callaghan, Michael, Pan-Petesch, Brigitte, Quon, Doris V., Andrews, Jayson, Trinh, Alex, Li, Mingjin, Wong, Wing Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063149/
https://www.ncbi.nlm.nih.gov/pubmed/35156839
http://dx.doi.org/10.1089/hum.2021.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063149/
https://www.ncbi.nlm.nih.gov/pubmed/35156839
http://dx.doi.org/10.1089/hum.2021.287

Ejemplares similares